Keywords: AstraZeneca, Teva, Entocort, Talampanel, Crohn's, ALS,

AstraZeneca grants Teva license to market generic Entocort in USA; Teva’s talampanel fails to meet primary endpoint

Article | 18 May 2010

Print This

Anglo-Swedish drug major AstraZeneca today announced that it has entered into an agreement with the US subsidiary of Israeli generics ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in